好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Tele-Neuro-Ophthalmology: An Update One Year Into The COVID-19 Pandemic
Neuro-ophthalmology/Neuro-otology
P16 - Poster Session 16 (8:00 AM-9:00 AM)
2-005

This study evaluates the usage of tele-neuro-ophthalmology one year into the pandemic.

Tele-neuro-ophthalmology emerged as a resource early in the COVID-19 pandemic. Since then, telehealth utilization has evolved.

Telehealth utilization pre-COVID-19, early pandemic (March, 2020), and 1 year later (March, 2021) was surveyed among practicing neuro-ophthalmologists in and outside the United States using an online platform. Demographics, utilization, perceived benefits, barriers, and data utility opinions were collected over a two-week period in May 2021, prior to the emergence of the Delta and Omicron variants.

135 practicing neuro-ophthalmologists (81.5% United States, 47.4% females) participated in the survey. One year into the pandemic, the proportion of respondents utilizing video telemedicine (50%) decreased from early-pandemic rates (65%) (p<0.0005, McNemar), but was sustained above pre-pandemic percentages (6%, p<0.0005, McNemar). 82% of current video users plan to continue video visits. Proportion of respondents using remote testing (42.2% vs 46.2%, p=0.45), virtual second opinions (14.5% vs 11.9%, p=0.38), eConsults (13.5% vs 16.2%, p=0.25), online portal communications, and remote interpretation of patient-submitted testing remained similar between March 2020 and 2021. The majority selected increased access to care, better continuity of care, and enhanced patient appointment efficiency as benefits, while reimbursement, liability, disruption of in-person clinic flow, limitations of video exams, and patient technology use were barriers. Many neuro-ophthalmic exam elements were deemed more suitable collected in a separate in-person visit rather than during a live video session, although respondents felt some exam components could be evaluated adequately via a virtual platform.

One year into the COVID-19 pandemic yet prior to the emergence of the Delta and Omicron variants, neuro-ophthalmologists have maintained telemedicine utilization at rates higher than pre-pandemic levels. Tele-neuro-ophthalmology remains a valuable tool in augmenting patient care.

Authors/Disclosures
Adrienne Ng, MD
PRESENTER
Dr. Ng has nothing to disclose.
Heather Moss, MD, PhD, FAAN (Spencer Center for Vision Research at Stanford) Dr. Moss has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Verana Health. Dr. Moss has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal Firms. The institution of Dr. Moss has received research support from NIH. The institution of Dr. Moss has received research support from Research to Prevent Blindness. Dr. Moss has received intellectual property interests from a discovery or technology relating to health care. Dr. Moss has received personal compensation in the range of $0-$499 for serving as a grant review panel with National Institutes of Health. Dr. Moss has a non-compensated relationship as a Board of Directors with North American Neuro-ophthalmology Society that is relevant to AAN interests or activities.
No disclosure on file
Melissa W. Ko, MD, FAAN (Indiana University Neuroscience Center) Dr. Ko has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Ko has received research support from HRSA. Dr. Ko has received research support from IU Health.